x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Wegovy

Inception Point Ai

This series on Wegovy provides an in-depth look into the popular weight loss medication. The first episode introduces Wegovy, explaining its mechanism, clinical trials, and patient eligibility. The second episode delves into the benefits and potential risks, including effectiveness, side effects, and comparisons with other treatments. The final episode covers practical considerations such as usage, lifestyle integration, cost, and future developments. This series offers a comprehensive understanding

health & fitness medicine

All Episodes

6:28

Wegovy Oral Pill Approved: Breakthrough Weight Loss...

Wegovy ·

2026/01/10

# The Wegovy Revolution: How the First Weight Loss Pill Is Transforming Obesity TreatmentDiscover the groundbreaking developments in weight management as host Alexandra Reeves explores Novo Nordisk's Wegovy pill - the first oral GLP-1 medication approved for weight loss. This episode unpacks everything from the pill's impressive 17% average weight reduction in clinical trials to crucial dosing instructions and common side effects patients should expect.Learn why this daily pill represents more than

en

6:23

Wegovy Revolution: How a Weight Loss Drug Is...

Wegovy ·

2026/01/03

# Global Pulse Podcast: How Canada's Generic Wegovy Approval Is Changing the Weight Loss Landscape in 2026Discover how Canada's groundbreaking approval of generic Wegovy is reshaping the future of weight loss medication globally. In this eye-opening episode of Global Pulse, host Alexandra Reeves explores the far-reaching implications of this historic decision allowing generic semaglutide to hit Canadian pharmacies as early as January 4th.Learn about Wegovy's impressive clinical results, with

en

6:19

FDA Approves Oral Wegovy: Novo Nordisk Launches...

Wegovy ·

2025/12/30

# Wegovy Pill: FDA Approves First Oral GLP-1 Therapy for Weight Management - Global Health Watch PodcastDiscover the groundbreaking FDA approval of Novo Nordisk's Wegovy pill, the first oral GLP-1 treatment for chronic weight management. Host Alexandra Reeves explores how this once-daily pill matches the impressive 16.6% weight loss results of injectable Wegovy without needles or refrigeration. Learn about the OASIS 4 trial results, pricing strategies, competitive landscape with Eli Lilly, and

en

6:15

FDA Approves First Oral Wegovy Pill for Weight Loss:...

Wegovy ·

2025/12/27

# FDA Approves Wegovy Pill: Revolutionary Oral Treatment for Weight Loss and Heart HealthDiscover how the new FDA-approved oral version of Wegovy is transforming obesity treatment. In this episode, we explore Novo Nordisk's groundbreaking weight loss pill that delivers comparable results to injectable treatments without the needles. Learn about the clinical trials where participants lost an average of 13.6% body weight over 15 months, the upcoming January 2024 release, and potential pricing starting

en

6:57

Novo Nordisk Wins FDA Approval for Groundbreaking...

Wegovy ·

2025/12/23

# Breakthrough Pill for Weight Loss: FDA Approves Novo Nordisk's Wegovy Oral MedicationDiscover how Novo Nordisk is revolutionizing obesity treatment with the FDA's approval of the Wegovy pill - the first oral GLP-1 medication for weight management. In this episode, Alexandra Reeves breaks down the groundbreaking announcement from December 22, 2025, exploring how this once-daily 25mg oral semaglutide matches the efficacy of injectable Wegovy while offering unprecedented convenience for

en

6:32

Wegovy Revolution: Higher Doses, Oral Pills, and the...

Wegovy ·

2025/12/20

# Wegovy's Evolution: Higher Doses, Oral Options, and the Changing Landscape of Obesity TreatmentJoin Alexandra Reeves for an in-depth exploration of Wegovy, the groundbreaking weight-loss medication that's transforming obesity treatment. This episode examines Novo Nordisk's push for a higher 7.2mg dose of Wegovy, which demonstrated an impressive 20.7% average body weight reduction over 72 weeks—significantly outperforming the current standard dose and placebo.## What You'll Learn:- How Wegovy is

en

6:15

Wegovy Breaks New Ground: European High Dose Approval...

Wegovy ·

2025/12/16

# Wegovy's Global Impact: New High-Dose Approvals & Breakthrough MASH TreatmentIn this eye-opening episode, we explore the rapidly evolving landscape of Novo Nordisk's groundbreaking weight loss medication, Wegovy. Discover how the European Medicines Agency just backed a higher 7.2mg dose showing impressive 20.7% average weight loss in clinical trials. Plus, learn about Health Canada's landmark approval of Wegovy as the first-ever treatment for non-cirrhotic metabolic dysfunction-associated

en

6:24

Novo Nordisk Advances Wegovy Weight Loss Treatment...

Wegovy ·

2025/12/13

# New High-Dose Wegovy Gets European Green Light: A Game-Changer in Obesity TreatmentIn our latest podcast episode, veteran journalist Alexandra Reeves explores the groundbreaking developments surrounding Novo Nordisk's Wegovy weight loss treatment. The European Medicines Agency's CHMP has just endorsed a powerful 7.2mg semaglutide dose that delivers remarkable results: patients lost an average of 20.7% body weight over 72 weeks, with one-third achieving 25%+ weight reduction.Discover how this

en

6:50

Weight Loss Revolution: How Novo Nordisk and Eli...

Wegovy ·

2025/12/09

# Weight Loss Revolution: Oral GLP-1 Pills on Horizon as Wegovy Price Cut Drives Surge in AccessExplore the transformative shifts in weight loss medication accessibility as host Alexandra Reeves reveals how Novo Nordisk's 40% Wegovy price reduction triggered a 70% sales jump and expanded market presence. This episode dives into the imminent arrival of oral semaglutide pills expected by 2026, promising comparable weight loss results without weekly injections. Learn about Eli Lilly's competing

en

6:11

Wegovy Price Cuts and Lawsuits Reshape Weight Loss...

Wegovy ·

2025/12/06

# Wegovy Podcast: Navigating the Revolution in Weight Loss Treatment and Its Far-Reaching ImpactDiscover the multifaceted world of Wegovy in this comprehensive podcast episode with Alexandra Reeves. From dramatic Medicare price negotiations to mounting lawsuits, regulatory shifts, and scientific breakthroughs, this episode unpacks how semaglutide is transforming healthcare, economics, and policy landscapes worldwide.The episode explores recent Medicare's 71% price reduction for seniors, bringing

en

5:19

Wegovy Breakthrough: Novo Nordisk Seeks FDA Approval...

Wegovy ·

2025/12/02

# New Wegovy Breakthrough: FDA Fast-Tracks Higher Dose for Enhanced Weight Loss ResultsDiscover the groundbreaking developments in obesity medicine as Alexandra Reeves explores Novo Nordisk's latest Wegovy innovation. This episode dives into the pharmaceutical giant's FDA application for a 7.2mg injection—nearly triple the current approved dose—under an expedited review process reserved for national health priorities.Learn about the remarkable STEP UP trial results where participants lost an average

en

6:03

Wegovy Weight Loss Drug Seeks Higher Dose Approval...

Wegovy ·

2025/11/29

# Weight Loss Breakthrough: New High-Dose Wegovy Could Transform Obesity TreatmentDiscover the groundbreaking developments in obesity treatment as veteran journalist Alexandra Reeves explores Novo Nordisk's submission for a powerful 7.2mg Wegovy dose—nearly triple the current strength. This episode dives into the impressive STEP UP trial results, where participants lost an average of 20.7% body weight, with one-third achieving at least 25% weight reduction. Beyond the headlines, Reeves provides

en

6:21

Wegovy: The Weight Loss Revolution Transforming...

Wegovy ·

2025/11/25

# Wegovy Revolution: Navigating Weight Loss Breakthroughs with Alexandra ReevesJoin veteran journalist Alexandra Reeves as she delivers a comprehensive exploration of the Wegovy phenomenon transforming weight management across America. This in-depth episode examines how semaglutide has evolved from a novel treatment to a healthcare revolution, with clinical trials showing impressive 15% body weight reductions and a 26% decrease in cardiovascular events among high-risk patients.Reeves masterfully

en

6:54

Wegovy Revolutionizes Weight Management with Price...

Wegovy ·

2025/11/24

# Wegovy Price Drop & Medical Breakthroughs: What You Need to Know | World Dispatch PodcastExplore the latest developments surrounding Wegovy, the groundbreaking weight loss medication making waves across healthcare and popular culture. In this episode of World Dispatch, host Alexandra Reeves breaks down Novo Nordisk's significant 30% price reduction for self-pay patients in the US, bringing costs down from $499 to $349 monthly at over 70,000 pharmacies nationwide.Discover Wegovy's expanding medical

en

6:28

Wegovy Breakthrough: Novo Nordisk Slashes Prices,...

Wegovy ·

2025/11/18

# The Science and Impact of Wegovy: Beyond Weight LossDiscover the latest developments in weight management as Alexandra Reeves dives deep into Novo Nordisk's groundbreaking announcement on Wegovy pricing. Learn how this GLP-1 medication is becoming more accessible with reduced costs for uninsured Americans—now $349 monthly instead of $500, with a limited-time introductory offer of just $199 for the first two months.This episode explores Wegovy's expanding medical applications beyond weight loss,

en

6:16

Oral Wegovy Breakthrough: Revolutionary Weight Loss...

Wegovy ·

2025/11/15

# From Weight Loss Breakthrough to Metabolic Health Revolution: The Evolution of WegovyDiscover how Wegovy (semaglutide) is transforming healthcare beyond weight management in this comprehensive episode. Host Alexandra Reeves explores Novo Nordisk's groundbreaking FDA application for an oral Wegovy pill that could eliminate injection barriers by 2026, promising 13% weight loss without needles. Learn how this GLP-1 medication is reshaping treatment approaches for obesity, metabolic conditions, and

en

7:34

Wegovy: Breakthrough Weight Loss Drug Sparks Medical...

Wegovy ·

2025/11/11

# Wegovy's Double-Edged Sword: Medical Breakthrough vs. Legal Battles in 2025In this riveting episode, veteran international correspondent Alexandra Reeves takes listeners on a comprehensive journey through the complex world of Wegovy - the weight loss medication making headlines for both its remarkable clinical success and mounting legal challenges. Discover how this GLP-1 medication is transforming obesity treatment while facing scrutiny over serious side effects including vision loss.Reeves

en

6:22

Wegovy Revolutionizes Obesity Treatment: Breakthrough...

Wegovy ·

2025/11/08

# Wegovy Revolution: Breaking Down the Latest Clinical Breakthroughs and Access ChangesDive deep into the transformative impact of Wegovy in this eye-opening podcast episode. Host Alexandra Reeves takes listeners to the frontlines of the obesity treatment revolution, unpacking the groundbreaking OASIS 4 trial results revealed at Obesity Week. Discover how the new oral semaglutide pill helped 71% of prediabetic patients normalize blood sugar levels and how patients losing 15%+ of body weight

en

6:18

Wegovy Revolutionizes Weight Management: Breakthrough...

Wegovy ·

2025/11/04

# Revolutionary Weight Loss: Wegovy's Impact Beyond the ScaleExplore the groundbreaking developments surrounding Wegovy (semaglutide) in this comprehensive podcast episode with Alexandra Reeves. Discover how this FDA-approved weight management medication is transforming healthcare across multiple dimensions - from surprising cardiovascular benefits independent of weight loss to its expanding use in pediatric patients. Learn about the upcoming oral formulation expected in 2025, evolving telehealth

en

6:26

Wegovy Revolutionizes Obesity Treatment Cutting US...

Wegovy ·

2025/11/01

# Wegovy Revolution: The Data Behind 2025's Weight Loss Breakthrough - Health Insights PodcastExplore the transformative impact of Wegovy (semaglutide) on America's obesity crisis in this comprehensive episode of Health Insights with Alexandra Reeves. Discover how this groundbreaking GLP-1 medication has contributed to the first decline in U.S. adult obesity rates in decades, from 40% to 37%, representing 7.6 million fewer Americans living with obesity.This episode dives deep into the latest

en

76 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown